|
Magnetic resonance and ultrasound imaging as biomarkers for detection and monitoring of Parsonage-Turner Syndrome (PTS) |
1 R21 TR003033-01A1 |
SNEAG, DARRYL |
NCATS |
2020 |
|
Development and validation of clinical outcome assessments in LGMD2A |
1 R21 TR003184-01 |
JOHNSON, NICHOLAS ELWOOD |
NCATS |
2020 |
|
Molecular and Cellular Basis of Neurodevelopmental Disorders |
1 R01 MH113948-01A1 |
POWELL, CRAIG M |
NIMH |
2020 |
|
Modeling Social and Non-Social Learning in Autism |
1 R01 MH116252-01A1 |
ROSENBLAU, GABRIELA |
NIMH |
2020 |
|
Characterization of the role of Fmr1 in oxytocin neuronal subtypes |
1 R01 MH117127-01A1 |
DÖLEN, GÜL |
NIMH |
2020 |
|
Integrating a Stepped Care Model of Screening and Treatment for Depression into Malawis National HIV Care Delivery Platform |
1 R01 MH117760-01A1 |
MCBAIN, RYAN K |
NIMH |
2020 |
|
Metabolic changes underlying 16p11.2 deletion syndrome |
1 R01 MH119173-01A1 |
SIVE, HAZEL L |
NIMH |
2020 |
|
Computational Modeling-Informed Reward Subgroups in Adolescent ADHD |
1 R01 MH119815-01A1 |
STEVENS, MICHAEL C |
NIMH |
2020 |
|
Cerebellum and cerebellar-regulated circuit contribution to Fragile X Syndrome |
1 R01 MH120069-01A1 |
TSAI, PETER T |
NIMH |
2020 |
|
Biobehavioral validation of the ADHD emotion dysregulation phenotype |
1 R01 MH120109-01A1 |
KARALUNAS, SARAH LYN |
NIMH |
2020 |